logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (i) Percentage distribution of route of administration amongst new clients with opioids as primary drug

CountryInjectSmoke/inhaleEat/drinkSniffOthersBase (known status)Status unknown
Bulgaria58.638.41.00.02.0991
Czech Republic71.012.512.14.50.022414
Denmark16.735.440.37.60.014419
Germany39.419.829.79.81.219811520
Ireland25.766.28.10.00.06668
Greece41.09.30.549.10.2107811
Spain(1)14.364.67.09.15.03403506
France14.710.86.467.60.5205780
Italy51.631.80.812.43.417044249
Cyprus75.920.41.91.90.0540
Latvia96.90.02.50.60.016019
Lithuania99.20.40.40.00.02443
Hungary59.913.617.48.40.72870
Malta64.624.70.49.40.92235
Netherlands(2)8.370.015.15.61.0410138
Austria32.24.517.146.20.265063
Slovakia80.915.72.21.10.0895
Finland66.70.017.915.50.0842
Sweden12.35.777.92.51.61220
United Kingdom(3)35.151.510.11.22.1195991724
Total39.640.07.310.62.5486184367

Notes:

 Only countries where there are clients reported with opiates as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Thursday, 17 July 2008